Financial Respite For Sangamo As Roche Signs Neurodegeneration Disease Pact

Deal Snapshot: The Swiss major has given Sangamo a cashflow injection in a deal to access two novel technologies to develop treatments for neurodegenerative diseases, including against tau for Alzheimer's.